SI-BONE, Inc. revised revenue guidance for the year 2023. The company is increasing its 2023 worldwide revenue guidance to be in the range of $132 million to $134 million from the previous guidance of $128 million to $131 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.99 USD | -0.38% | +0.46% | -38.11% |
07-01 | SI-BONE, Inc.(NasdaqGM:SIBN) added to Russell Small Cap Comp Value Index | CI |
07-01 | SI-BONE, Inc.(NasdaqGM:SIBN) added to Russell 3000 Value Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.11% | 535M | |
+75.69% | 12.57B | |
-28.01% | 7.02B | |
-2.09% | 6.09B | |
+10.01% | 5.24B | |
-18.23% | 4.76B | |
+15.57% | 4.11B | |
-22.78% | 3.74B | |
-20.84% | 2.99B | |
-1.24% | 2B |
- Stock Market
- Equities
- SIBN Stock
- News SI-BONE, Inc.
- SI-BONE, Inc. Revises Revenue Guidance for the Year 2023